Literature DB >> 15638230

Immunoglobulin M memory B cell decrease in inflammatory bowel disease.

A Di Sabatino1, R Carsetti, M M Rosado, R Ciccocioppo, P Cazzola, R Morera, F P Tinozzi, S Tinozzi, G R Corazza.   

Abstract

BACKGROUND &
OBJECTIVES: Memory B cells represent 30-60% of the B cell pool and can be subdivided in IgM memory and switched memory. IgM memory B cells differ from switched because they express IgM and their frequency may vary from 20-50% of the total memory pool. Switched memory express IgG, IgA or IgE and lack surface expression of IgM and IgD. Switched memory B cells derive from the germinal centres, whereas IgM memory B cells, which require the spleen for their survival and/or generation, are involved in the immune response to encapsulated bacteria. Since infections are one of the most frequent comorbid conditions in inflammatory bowel disease, we aimed to verify whether IgM memory B cell pool was decreased in Crohn's disease and ulcerative colitis patients. PATIENTS &
METHODS: Peripheral blood samples were obtained from 22 Crohn's disease patients, 20 ulcerative colitis patients, 22 healthy controls and 18 splenectomized patients. To analyse peripheral blood lymphocytes, flow cytometry was performed using anti-CD19, anti-CD22, anti-CD27, anti-IgM, anti-IgD and anti-CD38 monoclonal antibodies.
RESULTS: Circulating IgM memory B cells were significantly lower in Crohn's disease (median 7.1%, range 1.8-20.7) and ulcerative colitis patients (median 8.1%, range 2.1-18.8) in comparison to control subjects (median 14.0%, range 6.8-31.1). As expected, there was a highly significant difference in the proportion of IgM memory B cells between splenectomized patients (median 2.4%, range 0.9-6.9) and healthy controls. Crohn's disease patients with abscesses showed the lowest frequency of IgM memory B cells. DISCUSSION: Our findings show that peripheral IgM memory B cells are reduced in inflammatory bowel disease patients. Further studies are necessary to answer the question of whether high risk of infection (abscess development) is promoted by the reduction/depletion of IgM memory B-cell pool in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638230

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells.

Authors:  Cuixia Tian; Grace K Luskin; Kevin M Dischert; James N Higginbotham; Bryan E Shepherd; James E Crowe
Journal:  Mol Immunol       Date:  2006-12-29       Impact factor: 4.407

Review 2.  Human spleen microanatomy: why mice do not suffice.

Authors:  Birte S Steiniger
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

Review 3.  Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Authors:  Alicia C Marín; Javier P Gisbert; María Chaparro
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

4.  Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort.

Authors:  Paul U Cameron; Penelope Jones; Malgorzata Gorniak; Kate Dunster; Eldho Paul; Sharon Lewin; Ian Woolley; Denis Spelman
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.

Authors:  H Rabe; M Malmquist; C Barkman; S Östman; I Gjertsson; R Saalman; A E Wold
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

6.  Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease.

Authors:  Kazumasa Kawashima; Michio Onizawa; Tatsuo Fujiwara; Naohiko Gunji; Hidemichi Imamura; Kyoko Katakura; Hiromasa Ohira
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

7.  Case report: Single-cell mapping of peripheral blood mononuclear cells from a patient with both Crohn's disease and isolated congenital asplenia.

Authors:  Dan Pu; Lu Liu; Na Wang; Dandan Wang; Zhe Zhang; Baisui Feng
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

8.  Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease.

Authors:  Gholamhossein Fallahi; Asghar Aghamohammadi; Ahmad Khodadad; Mojtaba Hashemi; Payam Mohammadinejad; Hossein Asgarian-Omran; Mehri Najafi; Fatemeh Farhmand; Farzaneh Motamed; Khadije Soleimani; Habib Soheili; Nima Parvaneh; Behzad Darabi; Rasoul Nasiri Kalmarzi; Shabnam Pourhamdi; Hassan Abolhassani; Babak Mirminachi; Nima Rezaei
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

9.  Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.

Authors:  Xinrui Wang; Yanfang Jiang; Yonggang Zhu; Manli Zhang; Man Li; Hongjuan Wang; Pujun Gao
Journal:  J Cell Mol Med       Date:  2016-01-22       Impact factor: 5.310

10.  Human CD27+ memory B cells colonize a superficial follicular zone in the palatine tonsils with similarities to the spleen. A multicolor immunofluorescence study of lymphoid tissue.

Authors:  Marie Lettau; Annika Wiedemann; Eva Vanessa Schrezenmeier; Claudia Giesecke-Thiel; Thomas Dörner
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.